Related Experiment Video

Updated: Apr 12, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer

Wen-Long Zhang1, Wei Lv2, Suo-Zhu Sun3

  • 1General Surgery Department, The Second Artillery General Hospital of PLA, Beijing 100088, P.R. China.

International Journal of Oncology
|May 9, 2015
PubMed

Insights

MicroRNA-206 (miR-206) inhibits anaplastic thyroid cancer metastasis by targeting MRTF-A. This finding offers a potential therapeutic strategy for advanced thyroid cancer by degrading MRTF-A, a key factor in cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Anaplastic thyroid carcinoma (ATC) presents a poor prognosis due to limited effective therapies.
  • Understanding the molecular mechanisms driving ATC metastasis is crucial for developing novel treatments.

Purpose of the Study:

  • To investigate the role of MRTF-A and miR-206 in the metastasis of anaplastic thyroid cancer.
  • To elucidate the molecular pathway involving miR-206 and MRTF-A in ATC progression.

Main Methods:

  • Analysis of MRTF-A expression in primary versus metastatic ATC tissues.
  • In vitro studies assessing the effects of miR-206 and MRTF-A on cell migration and invasion.
  • Luciferase reporter assays to confirm the targeting of MRTF-A by miR-206.

Main Results:

  • MRTF-A expression was significantly upregulated in metastatic ATC tissues.
  • miR-206 expression was negatively correlated with metastasis and directly targeted MRTF-A.
  • Overexpression of miR-206 inhibited ATC cell invasion and migration, while its silencing promoted these processes.
  • Restoration of MRTF-A expression reversed the inhibitory effects of miR-206.

Conclusions:

  • miR-206 acts as a tumor suppressor in anaplastic thyroid cancer by inhibiting invasion and metastasis.
  • The miR-206/MRTF-A axis represents a potential therapeutic target for managing advanced thyroid cancer.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K